Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;47(6):923-929.
doi: 10.1080/02713683.2022.2045611. Epub 2022 Mar 23.

Outcomes of Primary Trabeculectomy versus Combined Phacoemulsification-Trabeculectomy Using Automated Electronic Health Record Data Extraction

Affiliations

Outcomes of Primary Trabeculectomy versus Combined Phacoemulsification-Trabeculectomy Using Automated Electronic Health Record Data Extraction

Jose R Davila et al. Curr Eye Res. 2022 Jun.

Abstract

Purpose: Cataract is a known effect of trabeculectomy (TE), but some surgeons are hesitant to perform combined phacoemulsification-TE (PTE) due to a risk of increased TE failure. Herein, we compare intraocular pressure (IOP) lowering between trabeculectomy (TE) and phacoemulsification-TE (PTE) and investigate factors that impact patient outcomes.

Methods: We performed a retrospective study of adults undergoing primary TE or PTE at our institution from 2010 to 2017. We used Kaplan-Meier survival analysis to investigate time to TE failure, and Cox proportional hazards modeling to investigate predictors of TE failure, defined as undergoing a second glaucoma surgery or using more IOP-lowering medications than pre-operatively.

Results: 318 surgeries (218 TE; 100 PTE) from 268 patients were included. Median follow-up time was 753 days. Mean baseline IOP was 21.1 mmHg. There were no significant differences in IOP between TE and PTE groups beyond postoperative year 1, with 28.9-46.5% of TE and 35.5-44.4% of PTE groups achieving IOP ≤10. Final IOP was similar in both groups (p = 0.22): 12.41 (SD 4.18) mmHg in the TE group and 14.05 (SD 5.45) in the PTE group. 84 (26.4%) surgeries met failure criteria. After adjusting for surgery type, sex, age, race, surgeon, and glaucoma diagnosis there were no significant differences in TE failure.

Conclusion: This study suggests there is no significant difference in the risk of TE failure in patients receiving TE versus those receiving PTE.

Keywords: Glaucoma, cataract, trabeculectomy, phaco-trabeculectomy, combined surgery, intraocular pressure.

PubMed Disclaimer

Conflict of interest statement

DECLARATION OF INTEREST

The authors report no conflicts of interest.

Figures

Figure 1:
Figure 1:
Violin plot demonstrating the distribution of intraocular pressures in the operative eyes at pre-operative baseline and all post-operative visits following trabeculectomy or phaco-trabeculectomy. POD = post-operative day, POM = post-operative month, POY = post-operative year.
Figure 2:
Figure 2:
Bar chart demonstrating the mean number of intraocular pressure-lowering medications used in the operative eye at pre-operative baseline and all post-operative visits following trabeculectomy or phaco-trabeculectomy. Whiskers indicate the standard error. POD = post-operative day, POM = post-operative month, POY = post-operative year.
Figure 3:
Figure 3:
Kaplan-Meier curves for composite outcome of receiving a greater number of glaucoma medications compared to pre-operative baseline or undergoing a second laser or surgical glaucoma procedure. Log-Rank test to compare eyes that underwent primary trabeculectomy (Trab) compared to those that underwent combined phacoemulsification and trabeculectomy (Phaco-Trab) did not show a significant difference in the chance of survival (p = 0.17).

Similar articles

Cited by

References

    1. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP, CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001. Nov;108(11):1943–53. - PubMed
    1. AGIS (Advanced Glaucoma Intervention Study) Investigators. The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol. 2001. Dec;119(12):1771–9. - PubMed
    1. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998. Oct;126(4):487–97. - PubMed
    1. Musch DC, Gillespie BW, Niziol LM, Janz NK, Wren PA, Rockwood EJ, Lichter PR, Collaborative Initial Glaucoma Treatment Study Group. Cataract extraction in the collaborative initial glaucoma treatment study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch Ophthalmol. 2006. Dec;124(12):1694–700. - PubMed
    1. Derick RJ, Evans J, Baker ND. Combined phacoemulsification and trabeculectomy versus trabeculectomy alone: a comparison study using mitomycin-C. Ophthalmic Surg Lasers. 1998. Sep;29(9):707–13. - PubMed

Publication types